$CWK

Cushman & Wakefield Ltd.

No enriched coverage for $CWK in the last 7 days.

No SEC Form 4 filings for $CWK in the last 30 days.

Med

Cushman & Wakefield PLC (NYSE:CWK) Given Consensus Rating of "Moderate Buy" by Brokerages

Cushman & Wakefield PLC (NYSE:CWK) has received a "Moderate Buy" consensus rating from ten analysts, with an average 12-month price target of $18.06. The company recently surpassed earnings expectations, reporting an EPS of $0.54 against an estimated $0.53, and revenues of $2.91 billion, marking a 10.8% year-over-year increase. Shares are currently trading around $14.84, with a market capitalization of $3.48 billion, and institutional ownership stands at 95.56%.

Cushman & Wakefield Plc Experiences Revision in Stock Evaluation Amid Market Fluctuations

Cushman & Wakefield Plc has seen an updated stock evaluation due to changing market conditions. The company's stock performance shows mixed technical signals and varied returns, outperforming the S&P 500 over the last year but struggling year-to-date. This revision highlights the complexities of its market position within broader economic trends.

Analysts Offer Insights on Real Estate Companies: Welltower (WELL) and Cushman & Wakefield (CWK)

Analysts have provided insights into real estate companies Welltower (WELL) and Cushman & Wakefield (CWK). KeyBanc analyst Austin Wurschmidt reiterated a Buy rating for Welltower with a $240.00 price target, while Barclays analyst Brendan Lynch maintained a Hold rating for Cushman & Wakefield with a $19.00 price target. The article details analyst consensus ratings, price targets, and recent stock performance for both companies.